Banque de Luxembourg Investments (BLI)’s ResMed RMD Stock Holding History

Banque de Luxembourg Investments (BLI)’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$41.3M	Sell	207,815 -7,674	-4%	-$1.59M	1.46%	18
2026 Q1	$51.5M	Hold	215,489	–	–	1.54%	17
2025 Q4	$52.4M	Sell	215,489 -34,798	-14%	-$8.9M	1.54%	16
2025 Q3	$67.9M	Sell	250,287 -39,600	-14%	-$10.8M	1.98%	10
2025 Q2	$73.9M	Sell	289,887 -51,500	-15%	-$12.3M	2.12%	8
2025 Q1	$74.9M	Buy	341,387 +15,400	+5%	+$3.6M	2.27%	9
2024 Q4	$74.8M	Buy	+325,987	New	+$78.5M	2.03%	9

Other funds holding RMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Banque de Luxembourg Investments (BLI)'s RMD Position: Q2 2026 in Review

Banque de Luxembourg Investments (BLI) reduced its ResMed (RMD) stake by 3.6% in Q2 2026, selling an estimated $1.59M and leaving 207,815 shares worth $41.3M. The position accounts for 1.46% of the portfolio, ranked #18.

Banque de Luxembourg Investments (BLI) first reported a position in RMD in Q4 2024 and has held it in 7 quarters since. The position peaked at $74.9M in Q1 2025. 891 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

Banque de Luxembourg Investments (BLI) held 207,815 shares of ResMed worth $41.3M as of Q2 2026.
Banque de Luxembourg Investments (BLI) sold 7,674 ResMed shares in Q2 2026, an estimated $1.59M.
ResMed made up 1.46% of Banque de Luxembourg Investments (BLI)'s portfolio in Q2 2026, its #18 holding.
Banque de Luxembourg Investments (BLI) first reported a position in ResMed in Q4 2024 and has held it in 7 quarters since.
Banque de Luxembourg Investments (BLI)'s ResMed position peaked at $74.9M in Q1 2025.
891 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Banque de Luxembourg Investments (BLI)'s 13F filing for Q2 2026, filed 10 Aug 2026.